US equities
|
MU
$904.90
▲+2.97%
NVDA
$217.09
▲+1.38%
AMZN
$262.45
▲+4.98%
TSLA
$368.06
▲+3.76%
AAPL
$342.94
▼-0.15%
SNDK
$1,371.12
▲+5.53%
META
$705.44
▼-0.55%
SPCX
$147.96
▲+1.32%
MU
$904.90
▲+2.97%
NVDA
$217.09
▲+1.38%
AMZN
$262.45
▲+4.98%
TSLA
$368.06
▲+3.76%
AAPL
$342.94
▼-0.15%
SNDK
$1,371.12
▲+5.53%
META
$705.44
▼-0.55%
SPCX
$147.96
▲+1.32%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Nick Kadysh
Recent news which mentions Nick Kadysh
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
April 19, 2023
Tickers
AWKNF
Tags
Financing
Global
Management
From
Benzinga
Clinical Grade 'LaNeo' MDMA Completes Release Testing And Is Ready For Export In Several Dosages
August 18, 2022
Tags
News
Benzinga
PharmAla Biotech Holdings Inc
From
Benzinga
This Specialized MDMA Producer Will Provide Psychedelics Exclusively For Canadian Massive Research Organization
August 05, 2022
Tags
Cannabis
Global
PharmAla Biotech Holdings Inc
From
Benzinga